Aarti Drugs Ltd - 524348 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Seema Harshit Savla AARTI DRUGS LTD. - 524348 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Seema Harshit Savla AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Acquisition
This is to inform you that Company has incorporated a Wholly Owned Subsidiary (WOS) Company namely 'Aarti Speciality Chemicals Limited' CIN No: U24230MH2019PLC333306 on November 20, 2019. AARTI DRUGS LTD. - 524348 - Compliance Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015
In compliance with Regulation 23(9) of SEBI (LODR) Regulations, 2015 we enclose disclosure of Related Party Transactions on a consolidated basis for the half year ended September 30, 2019. AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates / Issue of Duplicate Share Certificates under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. AARTI DRUGS LTD. - 524348 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Seema Harshit Savla Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Acquisition
Company has incorporated a marketing subsidiary namely 'Pinnacle Chile SpA' in Chile. Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release for September'19 AARTI DRUGS LTD. - 524348 - Certificate Pursuant To Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Certificate pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201 AARTI DRUGS LTD. - 524348 - Compliance Of Regulation 40(10) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended September 30, 2019
We are forwarding herewith Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 received from Jagdish Patel & Co., Practicing Company Secretary, for the half year ended September 30, 2019 for your perusal and record.